Tirzepatide10mgLabeled material quantity per vial
Peptides
Tirzepatide
A synthetic, lipid-modified peptide identified in the literature as LY3298176, with GIP and GLP-1 receptor activity in laboratory assays.
Pricing to be announcedSelected size10mg
SKU
HM-TIRZEPATIDE-10AvailabilityTo be announced
Lot-specific recordsOriginal COAs when publishedClear dispatch detailsConfirmed terms before sales openDirect supportProduct & document questions
Exclusively for laboratory research. Not for human or animal use. Vial sizes are labeled quantities, not administration instructions.
Compound information
About Tirzepatide
Tirzepatide is a synthetic peptide investigated using receptor-binding and cell-signaling assays. Published work describes a fatty-acid modification and activity at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. These are molecular characteristics, not a statement of clinical benefit or a test result for a Horizon vial.
- Reference identity
- Synthetic, lipid-modified peptide · LY3298176
- This selection
- 10mg · HM-TIRZEPATIDE-10
Scientific references
References describe the named compound. They are not COAs or evidence of testing for a Horizon lot.
Primary literature · PubMed ↗